Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | EDNRA | P25101 | 5/20 | 0.37 |
| ▸ | EDNRB | P24530 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.30 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19035941 | 0.98 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL12333547 | 0.98 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL19035979 | 0.96 | EDNRA (0.37) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL19036007 | 0.96 | KDM4E (0.38) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL19009421 | 0.95 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL19035973 | 0.95 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL19035980 | 0.95 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL19035960 | 0.95 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL22958756 | 0.95 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMEDNRAEDNRB | |
| SCHEMBL19035997 | 0.95 | KDM4E (0.38) | L3MBTL1KDM4EATMEDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336772-B2 | Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-02 | — | — | US | disclosed |
| US-20170183360-A1 | BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
| US-20170183360-A1 | BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336772-B2 | Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound | BRD1, CYP1B1, ARL1 | L3MBTL1 251/4885KDM4E 4064/4885ATM 986/4885 |
| US-20170183360-A1 | BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND | BRD1, CYP1B1, ARL1 | L3MBTL1 251/4885KDM4E 4064/4885ATM 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.